O'Shaughnessy Asset Management’s Axsome Therapeutics AXSM Stock Holding History

O'Shaughnessy Asset Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$265K	Sell	1,570 -800	-34%	-$138K	﹤0.01%	1843
2025 Q4	$433K	Buy	2,370 +40	+2%	+$5.58K	﹤0.01%	1574
2025 Q3	$283K	Buy	+2,330	New	+$262K	﹤0.01%	1780
2025 Q2	–	Sell	-3,104	Closed	-$362K	–	2385
2025 Q1	$362K	Buy	+3,104	New	+$354K	﹤0.01%	1476
2021 Q4	–	Sell	-1,336	Closed	-$44K	–	1356
2021 Q3	$44K	Hold	1,336	–	–	﹤0.01%	1689
2021 Q2	$90K	Buy	+1,336	New	+$80.2K	﹤0.01%	1347

Other funds holding AXSM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

O'Shaughnessy Asset Management's AXSM Position: Q1 2026 in Review

O'Shaughnessy Asset Management reduced its Axsome Therapeutics (AXSM) stake by 34% in Q1 2026, selling an estimated $138K and leaving 1,570 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #1843.

O'Shaughnessy Asset Management first reported a position in AXSM in Q2 2021 and has held it in 6 quarters since. The position peaked at $433K in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

O'Shaughnessy Asset Management held 1,570 shares of Axsome Therapeutics worth $265K as of Q1 2026.
O'Shaughnessy Asset Management sold 800 Axsome Therapeutics shares in Q1 2026, an estimated $138K.
Axsome Therapeutics made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q1 2026, its #1843 holding.
O'Shaughnessy Asset Management first reported a position in Axsome Therapeutics in Q2 2021 and has held it in 6 quarters since.
O'Shaughnessy Asset Management's Axsome Therapeutics position peaked at $433K in Q4 2025.
409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2026, filed 13 May 2026.